Madopar

We used positron emission tomography (PET) and the 18-flourodeoxyglucose tracer to study cerebral effects of complementary… Expand

In an open, uncontrolled study the longterm (9 years) effect of treatment with Madopar® alone (n=377) or in combination with l… Expand

The potentiation of the ami akinetic effect after L-Dopa treatment by an inhibitor of monoamine oxidase (MAO) “B”, Deprenil, has… Expand

In this Danish‐Norwegian randomized double‐blind parallel‐group multicentre study, we compared the therapeutic response of slow… Expand

For many patients with Parkinson disease and levodopa-related motor fluctuations, the latency to onset of action of a single dose… Expand

SummaryUrinary salsolinol output had been shown to be lower in Parkinsonian patients than in controls and to increase largely… Expand

The combinations of benserazide and levodopa (1:4, Madopar) and of carbidopa and levodopa (1:10 and 1:4, Sinemet) are currently… Expand

Eight healthy male and fasted volunteers received alternatively either one HBS capsule of Madopar 125 or two HBS capsules of… Expand

A sixteen‐week study examined the effect of Madopa and Sinemet on patients with Parkinson disease suffering nausea or vomiting as… Expand

In a clinical trial the effect of L-deprenil, a selective irreversible inhibitor of monoamine oxidase (M.A.O.) "type B" in… Expand